Search Results for: stap cell

Big patent & IP implications or even ‘war’ from STAP stem cells?

A new article in the major Japanese newspaper, Asahi Shimbun, just came out suggest major intellectual property (IP) and patent issues related to stem cells including the new stress induced STAP stem cells. The piece is entitled provocatively enough “Global patent war looms with epoch-making discovery of STAP cells“. That’s strong language. The article begins

Big patent & IP implications or even ‘war’ from STAP stem cells? Read More »

More thoughts from STAP acid reprogramming stem cell paper

The STAP papers on making iPS like cells using acid treatment of differentiated cells really has people talking. See embryo at right made from GFP reporter STAP cells that glow green. As I said in my review of the papers yesterday, there are still some critical things we do not know about STAP cells and I

More thoughts from STAP acid reprogramming stem cell paper Read More »

Weekly reads: abundant Abcam prices, speedy aging & cancer, stemmy CAR-T, more on STAP

Abcam prices

When a vendor of important reagents like antibody supplier Abcam charges big money, those high Abcam prices could negatively impact research in the long run. Some of the prices are so high that buying just a few antibodies could take up a small but meaningful slice of an entire R01 grant. Sky-high Abcam prices I’ve

Weekly reads: abundant Abcam prices, speedy aging & cancer, stemmy CAR-T, more on STAP Read More »

Weekly reads: late Macchiarini retractions, stem cells & Lululemon

Paolo-Macchiarini

Paolo Macchiarini is one of a small group of people in the stem cell universe whose misconduct has blown up in the press. Piero Anversa, Haruko Obokata, Hwang Woo-Suk, and some operators in the unproven stem cell clinic sphere come to mind. Macchiarini published quite a few seriously problematic papers, some of which just hung

Weekly reads: late Macchiarini retractions, stem cells & Lululemon Read More »

Weekly reads: big Retraction Watch news, stem cells & metastasis, an FDA approval, Iowa AG sues clinic

Retraction watch

Retraction Watch has been a great resource for those of us who have been following research misconduct. They widely cover and conduct research on retractions, corrections, and other developments in this space. Unfortunately, there’s been plenty to write about even just within the stem cell and cell therapy arena, which is my primary interest. Think

Weekly reads: big Retraction Watch news, stem cells & metastasis, an FDA approval, Iowa AG sues clinic Read More »

Weekly reads: stem cell for hair loss, clinic lawsuit update, 2 big retractions

stem cell for hair loss

There seems to be a never-ending supply of stem cell for hair loss research but a new article invokes a novel mechanism. Stem cell for hair loss research and cell mechanics Here’s a recent news item about a PNAS paper: Coaxing hair growth in aging hair follicle stem cells, NW Now. A common theme is things

Weekly reads: stem cell for hair loss, clinic lawsuit update, 2 big retractions Read More »

Heart stem cells trial mostly disappoints but is oversold

heart stem cells

Are there endogenous adult heart stem cells that are useful in cardiac disease or can stem cell infusions help ailing hearts? As to the first question, the adult heart does not appear to have meaningful numbers of true stem cells. Further, testing the idea of infusions of stem cells for heart disease has so far been giving

Heart stem cells trial mostly disappoints but is oversold Read More »

Paolo Macchiarini guilty in criminal stem cell case but does a Houdini again

Paolo-Macchiarini

Dr. Paolo Macchiarini exemplifies how things can change quickly in the stem cell world and go from sky highs to deep lows. Stem cell rollercoasters Over the years, a few academic stem cell researchers as well as some operators in the unproven clinic sphere have had dizzying ups and downs. There’s John Kosolcharoen. His company

Paolo Macchiarini guilty in criminal stem cell case but does a Houdini again Read More »